Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001909087 | SCV002173785 | benign | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004837822 | SCV005462546 | uncertain significance | not specified | 2024-09-10 | criteria provided, single submitter | clinical testing | The c.629G>A (p.R210H) alteration is located in exon 3 (coding exon 3) of the OAS1 gene. This alteration results from a G to A substitution at nucleotide position 629, causing the arginine (R) at amino acid position 210 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |